Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).

  • FEAnalytics.com
  • FEInvest.net
  • FETransmission.com
  • Investegate.co.uk
  • Trustnet.hk
  • Trustnetoffshore.com
  • Trustnetmiddleeast.com

For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.

WHAT INFORMATION DO WE COLLECT ABOUT YOU?

We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.

COOKIES

In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.

HOW WE USE INFORMATION

We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.

ACCESS TO YOUR INFORMATION AND CORRECTION

We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.

WHERE WE STORE YOUR PERSONAL DATA

The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.

CHANGES TO OUR PRIVACY POLICY

Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.

OTHER WEBSITES

Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.

CONTACT

If you want more information or have any questions or comments relating to our privacy policy please email [email protected] in the first instance.

 Information  X 
Enter a valid email address

Ideagen PLC (IDEA)

  Print      Mail a friend

Tuesday 18 July, 2017

Ideagen PLC

Final Results

RNS Number : 3048L
Ideagen PLC
18 July 2017
 

 

18 July 2017

Ideagen PLC

("Ideagen" "the Company" or "the Group")

 

Unaudited Preliminary Results for the Year Ended 30 April 2017

 

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management software to highly regulated industries, announces its unaudited preliminary results for the year ended 30 April 2017.

 

Financial Highlights

 

·    Revenue increased 24% to £27.1 million (FY2016: £21.9 million)

o Underlying organic growth* of 10% (FY2016: 10%)

o Run rate recurring revenues of £20.2 million at year end (FY2016: £11.9 million), covering 93% of operating costs (FY2016: 81%)

·    SaaS revenue increased 133% to £4.8 million (FY2017 : £2.1 million)

·    Adjusted diluted EPS*** increased 19% to 3.16 pence (FY2016: 2.66 pence)

·    Adjusted EBITDA** increased 26% to £7.9 million (FY2016: £6.3 million)

·    Adjusted PBT*** increased 22% to £6.9 million (FY2016: £5.7 million)

·    Cash generated from operations of £8.9 million (FY2016: £4.9 million)

·    Net cash of £4.2 million (FY2016: £6.3 million)

·    Proposed final dividend of 0.142 pence per share

o Making a total dividend of 0.21 pence per share for the year which represents a 15% increase over the FY2016 dividend of 0.183 pence per share

 

Operational Highlights

 

 ·   Acquisitions of Covalent, IPI, PleaseTech and Logen adding further IP, customers and recurring revenue to the Group

·    Strengthening of the Board through the addition of Ben Dorks as Chief Customer Officer and Barnaby Kent as Chief Operating Officer

·    Significant growth in SaaS business driven by investment in Coruson, Ideagen's cloud based Governance, Risk and Compliance (GRC) platform and the Group's acquisition strategy

·    45 new SaaS customer wins including British Airways, Ryanair, Johnson Matthey, Air Transat and Telefonica

·    Over 150 new on-premise customer wins including Babcock, Doncasters Group, KLM and Argenta Bank

·    Strong account management with significant contract extensions from SABIC, BDO, Jaguar Land Rover, Imperial Tobacco and DHL

·    Continued high levels of customer retention with support and maintenance contract renewal rate of 97% (FY2016: 96%)

·    Ongoing product innovation and investment across all products

 

 

*        Comparison calculated on a pro-forma basis as if acquisitions had been in the Group for the same period in the previous year

**      Before share based payments and exceptional items

***    Before share based payments, amortisation of acquisition intangibles and exceptional items                           

 

David Hornsby, CEO of Ideagen, commented: "The Group's focus this year was on the delivery of our organic growth objectives whilst continuing the execution of our buy and build strategy which resulted in four valuable acquisitions. We are delighted to report another year of strong growth, which has been underpinned by excellent cash generation and has augmented our position as a leader in the Governance, Risk and Compliance (GRC) market.

 

Trading since the year end has remained robust and we continue to see strong demand for our products from new potential customers. Moreover our growing recurring revenues and the repeat business derived from more than 3,000 customers, an increase of over 800 from last year, provides the Board with confidence in the prospects for the Group for the current year and beyond."

 

 

 

Enquiries:

 

Ideagen plc

01629 699100

David Hornsby, Chief Executive

 

Graeme Spenceley, Finance Director

Joe O'Brien, Investor Relations

 

 

 

finnCap Limited

020 7220 0500

Henrik Persson (Corporate Finance)

 

Stephen Norcross (Corporate Broking)

 

 

 

 

About Ideagen plc

Ideagen is a UK company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L). Ideagen is a supplier of Information Management software with operations in the UK, the United States and the Middle East. The Company specialises in Governance, Risk and Compliance (GRC) and Healthcare solutions for organisations operating within highly regulated industries. With an excellent portfolio of software products, Ideagen is able to provide complete information lifecycle solutions that enable our customers to meet their regulatory and quality compliance standards, helping them to mitigate risks and achieve operational excellence

 

The Group has a customer base of over 3,000 organisations using the Ideagen suite of products, including many blue chip names such as BAE Systems, Emirates, Shell and the European Central Bank as well as 180 hospitals in the UK and US.

 

 

 

CHAIRMAN'S STATEMENT

 

I am pleased to report on another strong performance for the year to 30 April 2017, representing Ideagen's 8th consecutive year of revenue and EBITDA growth. The Group met or exceeded all key financial and operational objectives for the year covering revenue, profitability, organic growth, cash generation and customer retention.

 

These results demonstrate that Ideagen has scale, a world class customer base, an outstanding product set and a proven and effective management team. This year's focus has been a combination of organic growth combined with a return to the execution of our buy and build strategy.

 

The Board believes the long term prospects for the Group are positive.  The Governance, Risk and Compliance (GRC) market was, according to Gartner, worth $4.4 billion globally in 2016 and is estimated to be growing at 13% per annum. We believe that we have established a compelling business platform that has been enhanced by the four acquisitions made this year and are well placed to participate in this growth.

 

Highly regulated organisations require the tools we provide to help them identify, assess and manage corporate risk while complying with international industry standards, and many are only in the early stages of adopting an enterprise-wide approach. The Board believes that the Group's cloud solutions will be a particular growth area for the company which will increase the percentage of total revenues derived from recurring contracts providing even greater visibility of earnings.

 

In January Ben Dorks and Barnaby (Barney) Kent joined the Board as Chief Customer Officer and Chief Operating Office respectively, both Ben and Barney joined ideagen through the acquisition of Plumtree in 2013. Since then both have taken on increasing levels of responsibility, consistently met challenging business objectives and have developed as outstanding business leaders. Ben and Barney have been fundamental to the successful execution of the Group's growth strategy and are now contributing effectively at board level. We continue to review the optimum board structure and will look to further strengthen the team at Non-Executive level in due course.

 

In line with our progressive dividend policy and reflecting our continued confidence in the prospects for the Group, the Board is pleased to propose a final dividend of 0.142 pence per share making a total dividend of 0.21 pence for the year (FY2016: 0.183 pence) an increase of 15%. Subject to approval at the forthcoming AGM, the final dividend will be payable on 22 November 2017 to shareholders on the register on 3 November 2017. The corresponding ex-dividend date is 2 November 2017.

 

The success of Ideagen is the result of the excellence and dedication of our employees and on behalf of the Board I should like to thank all of them for their continued hard work. The new financial year has started well and I look forward to continued growth.

 

Jonathan Wearing

Non-Executive Chairman

 

 

CHIEF EXECUTIVE'S REVIEW

 

Business Review

 

I am pleased to report on another excellent performance for the twelve months ended 30 April 2017 during which we achieved strong organic revenue growth* of approximately 10% and made four important acquisitions each of which made a contribution in the year .

 

Total revenue of £27.1 million (2016: £21.9 million) represented overall growth of 24% and adjusted EBITDA grew 26% to £7.9 million (2016: £6.3 million), each slightly ahead of expectations. A key financial metric for the Group continues to be adjusted EPS and I am pleased to report an increase in adjusted diluted EPS of 19% to 3.16 pence for the year (FY2016: 2.66 pence).

 

Our early visibility of revenue ahead of expectations enabled the Group to bring forward the investment in a number of sales, marketing and technology initiatives that had been planned for the current year. This additional investment has provided additional resource, technology and infrastructure to further support the Group's growth strategy.

 

Net cash at the end of the year of £4.2million was also ahead of expectations following strong cash generation, particularly during the second half. Outstanding acquisition-related borrowings at 30 April 2017 of £2million were repaid shortly after the year end, and consequently the Group has now returned to having a debt free balance sheet.

 

The Group continues to benefit from a strong and growing base of recurring revenues, which represented 57% of total revenue in the year (2016: 54%). The Group is committed to increasing the percentage of total revenue derived from recurring contracts through the medium term transition from a traditional licence model to a SaaS subscription based model. This transition is well underway and recurring SaaS revenues represented 18% of total revenues within the year (2016: 9%). 

 

GRC represents the large majority of Ideagen revenues at 84% and continues to be the primary engine of growth for the Group. GRC provides software tools that enable customers to identify, assess and prioritise risk and to manage information in line with rigorous regulations. In each of our chosen verticals, our customers are increasingly required to take a holistic view of risk management, internal audit and compliance, with many organisations at the beginning of the adoption phase of high value enterprise-wide solutions.

 

In order to drive growth we have successfully added new customers to the Group across all of our key GRC verticals, with aviation, life sciences and financial services providing particularly notable success in the year. We also continue to maintain a focus on product enhancement and innovation which has seen acceptance across the user base, resulting in significant revenues from strong retention of recurring contracts and new projects from our extensive customer base.

 

As in the previous two financial years the clinical management solutions market continues to be impacted by the uncertainty of funding for acute NHS Trusts. However our existing customers in this market continue to provide us with strong levels of recurring revenues, adding to the underlying financial strength of the business. 

 

Following the previous year, during which the Board decided not to make any acquisitions, the Group re-embarked on the execution of its proven buy and build strategy. Ideagen had been aware of all four companies acquired for a number of years and had been tracking their progress carefully. The acquisitions made during the year were :

 

·     Covalent, a supplier of risk assurance and performance management software to the Public Sector and Financial Services;

·     IPI, a supplier of quality reporting software to the Aerospace and Defence Industry;

·     PleaseTech, a supplier of document review and control software primarily to Life Sciences industry

·     Logen, a Bulgarian reseller of ''Ideagen Pentana'' our audit management product.

 

Each of the acquisitions are performing well by adding intellectual property, recurring revenues, vertical market consolidation and technical expertise to the Group and will form part of our enlarged GRC business.

The acquisition of PleaseTech was funded primarily by an oversubscribed share placing of £10 million which completed in March. The Board remains committed to an ongoing buy and build strategy and would expect to complete further acquisitions in the future assuming targets meet our criteria and represent value for shareholders.

   

Markets and Product Strategy

 

Ideagen's product and market strategy is geared to market penetration horizontally in governance, risk and compliance and vertically in transport, advanced manufacturing, life science, healthcare and financial services. As an acquisitive Plc, we both acquire and develop new products and continue to identify acquisitions that support our market penetration approach.

 

We have subject matter expertise and decades of experience in our vertical markets and in our technology domains. These are as follows:

 

GRC Domains:

           ·    Quality Management

           ·    Safety Management

           ·    Risk Management

           ·    Audit Management

           ·    Performance Management

 

Vertical markets:

           ·    Transport

           ·    Advanced Manufacturing

           ·    Life Science

           ·    Government

           ·    Healthcare

           ·    Financial Services

 

We develop and sell software products that satisfy our customers' critical needs at the intersection of these domains and markets. Thus, we primarily provide risk based quality and safety management software to transport, manufacturing, life science and healthcare and risk based audit and performance software to  financial services, accounting firms and the public sector.

 

Due to the horizontal nature of GRC the Group can also supply to other vertical markets, for example Oil and Gas and Construction and it is likely that additional key vertical markets will evolve over time.

 

Clinical Workflow

 

Ideagen also provides clinical workflow software solutions to the UK NHS where trusts are seeking to modernise and transform processes by digitising medical records. The primary goal of this transformation is to improve patient outcomes and care quality while also generating efficiency savings. The NHS is aiming to implement widespread modernisation and digitisation of working practices. Ideagen clinical workflow and hospital information management solutions have been designed in close collaboration with NHS customers to deliver innovation and improvements in quality, performance and productivity

 

Sales and Marketing Review

 

Our marketing objectives are to generate qualified sales leads and to enhance the global recognition and reputation of our brand and solutions. This is achieved through content driven product and vertical marketing covering blogs, white papers, webinars, a dedicated digital team and over 50 global events per year. Our principal marketing initiatives target key executives and decision makers within our existing and prospective customer base.

 

We sell our products primarily through a direct sales force which generate 93 percent of Group revenue and also through relationships with resellers. Our sales force operates globally with a focus on UK, Europe, North America, and Asia. The team is organized by both vertical market and function area and includes 40 'quota carrying' sales executives and account managers supported by technical sales and domain experts. We generate revenues from sales to new customers and through repeat licence and services sales to our existing customers.

 

 

 

 

Customer Examples

 

Ideagen Coruson at Johnson Matthey - Cloud Based Risk and Quality Management

 

Operating across a number of highly-regulated industries, Johnson Matthey is required to conduct stringent testing of its products which includes unique and specialised detection, diagnostic and measurement solutions in order to achieve and maintain compliance to a series of industry standards.

 

Among those standards includes ISO 9001. Using a previous software system for general quality management and business performance reporting, Johnson Matthey's day-to-day quality processes were "manual, slow and laborious".

 

Ideagen Coruson, Ideagen's cloud-based software solution, was rolled out by the company to address those issues, initially being adopted as a dedicated quality solution.

Rachel Burke, Global Quality Manager at Johnson Matthey, said: "We had planned on using Ideagen Coruson to modernise our legacy quality system - such as managing non-conformances, customer complaints, document management and supplier issues. What we found, was that the system was so user friendly, effective and popular among staff that it is now used for risk based processes and procedures outside of our initial scope."

 

Ideagen Q-Pulse at Doncasters Group - On Premise Quality Management

 

Doncasters Group Ltd required a quality management solution which would successfully bring together all of their business processes and allow them to be managed from one central and electronic place.

 

Since initial implementation, the Q-Pulse software has been expanded within the Doncasters Group. From its initial Bramah installation in Sheffield, they now have four sites in the UK using the software extensively to manage tasks such as non-conformance management as well as the tracking of maintenance, recalls and calibration data.

 

Peter Rowe, VP of Quality at Doncasters Group, said: "The Q-Pulse product has taken many of the human issues out of quality management and this has resulted in an increase in quality levels - as well as an awareness of quality in general - at all of our sites currently using the system."

 

Ideagen Pentana at Argenta Bank - Internal Audit and Risk Management

 

Following the success of the Pentana auditing software within its Internal Audit and Risk Management departments, Argenta, a Bank based in Belgium and operating across the BENELUX region, has turned its attention to transforming the operational performance of its Inspection team using the same software.

 

With over 500 branches requiring regular visits each year, Argenta's Inspection team was continuously battling issues during each visit, mostly related to their use of a series of manual, paper-based methods.

 

During each visit, Argenta's inspectors are required to run various tests and document many observations and results. With each inspection lasting just one day, Argenta's Inspection team has limited time.

 

By implementing Pentana, paper-based and manual processes which were obstructing inspectors during their on-site reviews, were removed. Now, the Inspection team uses Pentana to perform inspections of Argenta's local branches, to document their findings, recommendations and actions electronically in a consistent way and to deliver the outputs in a standardised and easy to consume report. In short, Argenta's Inspection team's processes are now solid and consistent while objective measurement is now possible and action follow-up automatic.

 

Christel Van Camp, Process Manager within the department of Compliance and Integrity at Argenta, said: "Because our inspectors do not have to deal with potential barriers of paper-based systems and processes, our inspections now generate around 50% more output while re-work and other manual tasks have significantly decreased."

 

Outlook

 

Trading since the year end has remained robust and we continue to see strong demand for our products from new potential customers. With acquisitions made during the previous year performing well, and with a base of over 3,000 customers generating growing recurring revenues and repeat business the Board has every confidence in the continued prospects for the Group.

 

David Hornsby

Chief Executive Officer

 

 

 

 

FINANCIAL and OPERATIONAL REVIEW

 

Financial Review

 

Revenue for the year ended 30 April 2017 increased by 24% to £27.1 million (FY2016: £21.9 million). Within this, pro-forma organic revenue growth was, like last year, approximately 10%. This is calculated based on a comparison with pro-forma revenue for FY2016 of £24.6 million which includes revenues for Covalent, IPI, PleaseTech and Logen for the same period that they were owned by the group in FY2017.

 

The Group provides software solutions in two areas; GRC and Content and Clinical.

 

Revenues from the GRC market of £22.7 million represented 84% (FY2016: 80%) of total Ideagen revenues. This continues to be the main area of focus for the Group, and the proportion of overall revenues that it represents will increase further in coming years with the effects of full years' contributions from the acquisitions made during this year. Pro-forma organic revenue growth in GRC was 13% during the year (FY2016: 23%).

 

Content and Clinical, which accounts for 16% or £4.5million of Group revenues (FY2016: 20% and £4.4 million) is predominantly focused on content and clinical management for the NHS. It has seen revenues decline in recent years however this pattern has now stabilised with revenues growing by 1% in the year.

 

Recurring revenues have grown strongly this year, both because of the Group's continued focus on SaaS-based products, and through acquisitions of companies with high levels of recurring revenues. Recurring revenues were £15.5 million (FY2016: £11.9 million) making up 57% (FY2016: 54%) of total revenues and are equivalent to 93% (FY2016: 81%) of operating costs. This proportion will increase further with a full contribution from the acquisitions; the Group particularly considers high recurring revenue models as a key feature for acquisition targets.

 

With the increased focus on SaaS software sales, on-premise software licence revenues represented a declining proportion of revenues at 20.3% (FY2016: 24.0%) or £5.5million (FY2016: £5.3million) of total revenues as expected. Maintenance and Support revenues on traditional licence sales continued to grow in value terms however, for the same reasons, this also represents a reducing proportion of total revenues at 39.4% (FY2016: 45.1%). Professional services revenues represented a relatively stable proportion of total sales at 21.1% (FY2016: 20.2%). Revenues are analysed by revenue stream in note 2.

 

Adjusted EBITDA increased by 26% to £7.9 million (FY2016: £6.3 million) and the adjusted EBITDA margin at 29.0% remained at a similar level to FY2016 (28.5%). We consider it important to invest significantly in our staff and the infrastructure of the business to support continued organic growth and to provide a strong, scalable platform for the integration of future acquisitions.

 

Amortisation of acquisition intangibles of £4.3 million (FY2016: £3.7 million) represents the majority of the total depreciation and amortisation charge of £5.3 million (FY2016: £4.3 million). Amortisation of development costs amounted to £0.7 million (FY2016: £0.4 million). The share-based payment charge of £1.2 million (FY2016: £0.9 million) relates to the Group's equity-settled share option schemes and included £0.3million of national insurance costs on the exercise of non-tax efficient options. The remainder of the charge does not represent a cash cost to the Group.

 

The adjusted Group tax charge is analysed in note 5 and amounted to £0.8 million (FY2016: £0.7 million). This has been adjusted to exclude the deferred tax effects associated with the amortisation of acquisition intangibles and share based payment charges. The adjusted Group tax charge represents 12% (FY2016: 12%) of adjusted profit before tax of £6.9 million (FY2016: £5.7 million). The Group's use of tax losses, R&D tax credit claims and tax deductions linked to the exercises of share options means there is no UK corporation tax liability on FY2017 profits.

 

As a result of the above, adjusted diluted earnings per share increased by 19% to 3.16p (FY2016: 2.66p).

 

The Group's financial position has continued to strengthen during the year with net assets increasing to £46.4 million (FY2016: £33.7 million).

 

The level of intangible assets increased to £56.4 million (FY2016: £32.6 million) mainly as a result of the four acquisitions completed during the year. The Group capitalised £2.0 million (FY2016: £1.6 million) of R&D development costs during the year which represented 7.3% (FY2016: 7.5%) of total revenues. The increase is due to costs capitalised in respect of the products being developed by the businesses acquired during the year.

 

The acquisitions made during the year were funded through a combination of the Group's existing resources, an over-subscribed £10million share placing, deferred consideration payments agreed as part of the deals and the entry into a revolving working capital facility to cover short-term financing needs. At 30 April 2017, £2million of this revolving facility was still being utilised however this has been repaid since the year end, and accordingly, the Group currently has no material external borrowings outstanding.

 

Cash generated by operations improved significantly during the year and amounted to £8.9 million (FY2016: £4.9 million) representing cash conversion of approximately 113% (FY2016: 78%) of adjusted EBITDA.  The Board has set a cash conversion target of 90% and therefore the performance in the year represents significant over achievement. It is however important to note that this figure was positively impacted by the receipt, prior to the year-end of £0.8million of cash from option holders who have exercised options near the end of the financial year to cover payroll taxes arising on the exercise. This sum was paid out after the year end. Excluding this sum, cash generated by operations would have represented approximately 103% of adjusted EBITDA. Free Cash flow also improved significantly to £6.1 million (FY2016 £2.8 million) representing 77% (FY2016: 45%) of adjusted EBITDA. The group ended the year with net cash balances of £4.2 million.

 

During the year, the Group made the final deferred consideration payment of £1.6 million in respect of the acquisition of Gael Ltd. The Group also expects to pay a total of approximately £4.2m over the next two years in respect of contingent or deferred consideration on acquisitions completed in the year.

 

 

Operational Review

 

Ideagen has a strong cultural drive towards operational excellence focused around its people, processes, systems and facilities. At 30 April 2017 Ideagen had 363 employees based across its UK and international office network, with over 230 of these located at the 2 core UK offices of Nottingham and East Kilbride. Ideagen maintains an international office presence in the US, Dubai, Bulgaria, and Malaysia, where a combined total of 41 people are based.

 

The organisation remains committed to significant investment in R&D, with 95% of resources based at the core R&D sites in Nottingham, East Kilbride, Bulgaria, and Malaysia. Ideagen maintains its focus building upon core markets, both geographically and vertically, and delivering excellence across the customer base. As a result the company has 77 people within Sales & Marketing, 68 in Service Delivery, and 43 in Support.

 

Ideagen is pleased to combine success with continued investment in the team, and 52% of employees have been with the Group for 3 or more years. The Group is delighted that this traditionally male dominated sector has seen strong growth in female applications, resulting in a ratio of 71% male to 29% female.

 

In order to facilitate the growth of recent years, Ideagen continues to invest significantly in 'best of breed' systems that have scalability, functionality and reporting at their core. Salesforce.com remains the number one system for the organisation, providing both the internal platform for sales, marketing, and service delivery and the external platform for self-service support portals for our customers.

 

As Ideagen develops, significant resource is invested in benchmarking processes and systems to ensure best practice is standard and that Ideagen remains fit for growth. Ideagen remains committed to relevant accreditations and currently holds Microsoft Gold Partner status, ISO 9001, ISO 27001, and ISO 14001. The company has membership to a significant number of leading bodies including the Chartered Quality Institute (CQI), Institute of Internal Auditors (IIA), Airports Council International Europe (ACI), and the Institute of Biomedical Science (IBMS).

 

 

 

Graeme Spenceley

Chief Financial Officer

 

Ideagen plc

 

Group Statement of Comprehensive Income for the year ended 30 April 2017

 

 

Note

2017

 

2016

£'000

£'000

Revenue

2

27,112

 

21,936

Cost of sales

 

(2,841)

 

(2,632)

Gross profit

 

24,271

 

19,304

Operating costs

 

(16,404)

 

(13,047)

Profit from operating activities before depreciation, amortisation, share-based payment charges and exceptional items

 

7,867

 

6,257

 

 

 

 

 

Depreciation and amortisation

 

(5,255)

 

(4,322)

Costs of acquiring businesses

 

(609)

 

-

Restructuring costs

 

(104)

 

-

Share-based payment charges

 

(1,203)

 

(936)

Profit from operating activities

 

696

 

999

 

 

 

 

 

Movement in fair value of contingent consideration

 

-

 

(4)

Finance (costs) / income

 

(33)

 

7

Profit before taxation

 

663

 

1,002

Taxation

4

68

 

315

Profit for the year

 

731

 

1,317

 

 

 

 

 

Other comprehensive income

 

 

 

 

Items that may be subsequently reclassified to profit or loss:

 

 

 

 

Exchange differences on translating foreign operations

 

252

 

88

Corporation tax on exercise of options

 

277

 

27

 

 

 

 

 

Total comprehensive income for the year attributable to the owners of the parent company

 

1,260

 

1,432

 

 

 

 

 

Unadjusted earnings per share

3

Pence

 

Pence

Basic

 

0.40

 

0.74

Diluted

 

0.38

 

0.71

 

 

 

 

 

Adjusted earnings per share

3

Pence

 

Pence

Basic

 

3.32

 

2.78

Diluted

 

3.16

 

2.66

 

 

 

  Ideagen plc

 

Group Statement of Financial Position at 30 April 2017

 

 

 

 

 

 

Assets and liabilities

 

 

 

 

Non-current assets

 

 

 

 

Intangible assets

 

56,427

 

32,572

Property, plant and equipment

 

583

 

433

Deferred income tax assets

 

1,348

 

877

 

 

58,358

 

33,882

Current assets

 

 

 

 

Inventories

 

10

 

33

Trade and other receivables

 

10,971

 

8,244

Current income tax recoverable

 

27

 

-

Cash and cash equivalents

 

6,205

 

6,317

 

 

17,213

 

14,594

Current liabilities

 

 

 

 

Trade and other payables

 

5,115

 

2,506

Contingent consideration on business combinations

 

2,054

 

-

Current income tax liabilities

 

-

 

13

Short-term borrowings

 

2,000

 

-

Deferred revenue

 

11,609

 

6,603

Deferred consideration on business combinations

 

1,640

 

1,623

 

 

22,418

 

10,745

Non-current liabilities

 

 

 

 

Deferred consideration on business combinations

 

460

 

-

Deferred income tax liabilities

 

6,274

 

4,048

 

 

6,734

 

4,048

 

 

 

 

 

Net assets

 

46,419

 

33,683

 

 

 

Ideagen plc

 

Group Statement of Financial Position at 30 April 2017 (continued)

 

 

 

 

 

 

 

 

 

Equity

 

 

 

 

 

 

 

Issued share capital

 

1,981

 

1,790

Share premium

 

33,405

 

23,598

Merger reserve

 

1,658

 

1,167

Share-based payments reserve

 

961

 

1,482

Retained earnings

 

8,081

 

5,565

Foreign currency translation reserve

 

333

 

81

 

 

 

 

 

Equity attributable to the owners of the parent

 

46,419

 

33,683

 

 

Ideagen plc

 

Group Statement of Cash Flows for the year ended 30 April 2017

 

 

2017

 

2016

 

 

£'000

 

£'000

 

Cash flows from operating activities

 

 

 

 

 

 

Profit for the year

 

 

731

 

1,317

 

Depreciation of property, plant and equipment

 

249

 

201

 

Amortisation of intangible non-current assets

 

5,006

 

4,121

 

(Profit)/loss on disposal of property, plant and equipment

 

(14)

 

3

 

Share-based payment charges

 

 

1,203

 

936

 

Finance costs/(income) recognised in profit or loss

 

33

 

(7)

 

Taxation credit recognised in profit or loss

 

(68)

 

(315)

 

Business acquisition costs in profit or loss

 

609

 

-

 

Movement in fair value of contingent consideration

 

-

 

4

 

Decrease in inventories

 

23

 

22

 

Increase in trade and other receivables

 

(1,395)

 

(834)

 

Increase/(decrease) in trade and other payables

 

1,237

 

(894)

 

Increase in deferred revenue liability

 

1,264

 

348

 

Cash generated by operations

 

 

8,878

 

4,902

 

Finance (costs paid)/income received

 

(33)

 

7

 

Income tax paid

 

(14)

 

(41)

 

Business acquisition costs paid

 

(390)

 

(92)

 

Employer's national insurance paid on share-based payments

 

(108)

 

-

 

Net cash generated by operating activities

 

8,333

 

4,776

 

 

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

 

 

Net cash outflow on acquisition of businesses net of cash acquired

 

(16,394)

 

-

 

Payments of deferred consideration on business combinations

 

(1,623)

 

(1,618)

 

Payments of contingent consideration on business combinations

 

-

 

(51)

 

Payments for development costs

 

(1,988)

 

(1,643)

 

Payments for property, plant and equipment

 

(289)

 

(347)

 

Proceeds of disposal of property, plant and equipment

 

23

 

11

 

Net cash used in investing activities

 

(20,271)

 

(3,648)

 

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

Proceeds from placing of equity shares

 

10,000

 

-

 

Payments for share issue costs

 

(334)

 

-

 

Proceeds from issue of shares under the share option schemes

 

324

 

172

 

New short-term borrowings

 

2,000

 

-

 

Equity dividends paid

 

(346)

 

(306)

 

Net cash generated/(used) by financing activities

 

11,644

 

(134)

 

 

 

 

 

 

 

Net (decrease)/increase in cash and cash equivalents during the year

 

(294)

 

994

 

Cash and cash equivalents at the beginning of the year

 

6,317

 

5,266

 

Effect of exchange rate changes on cash balances held in

foreign currencies

 

182

 

57

 

Cash and cash equivalents at the end of the year

 

6,205

 

6,317

 

 

Ideagen plc

Group Statement of Changes in Equity for the year ended 30 April 2017

 

Share

capital

 

Share

premium

 

Merger

reserve

 

Share-based payments reserve

 

Retained earnings

 

Foreign

currency translation reserve

 

Total

attributable to owners of the parent

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

£'000

 

£'000

 

 £'000

 

£'000

 

£'000

 

   £'000

 

£'000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 1 May 2016

1,790

 

23,598

 

1,167

 

1,482

 

5,565

 

81

 

33,683

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Share placing

133

 

9,867

 

-

 

-

 

-

 

-

 

10,000

Share placing issue costs

-

 

(335)

 

-

 

-

 

-

 

-

 

(335)

Shares issued on acquisition of business

9

 

-

 

491

 

-

 

-

 

-

 

500

Shares issued under share option scheme

49

 

275

 

-

 

-

 

-

 

-

 

324

Share-based payments

-

 

-

 

-

 

858

 

-

 

-

 

858

Transfer on exercise of share options

-

 

-

 

-

 

(1,379)

 

1,379

 

-

 

-

Taxation on share-based payments in equity

-

 

-

 

-

 

-

 

475

 

-

 

475

Equity dividends paid

-

 

-

 

-

 

-

 

(346)

 

-

 

(346)

Total transactions with owners recognised directly in equity

191

 

9,807

 

491

 

(521)

 

1,508

 

-

 

11,476

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Profit for the year

-

 

-

 

-

 

-

 

731

 

-

 

731

Other comprehensive income for the year

-

 

-

 

-

 

-

 

277

 

252

 

529

Total comprehensive income for the year

-

 

-

 

-

 

-

 

1,008

 

252

 

1,260

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 30 April 2017

1,981

 

33,405

 

1,658

 

961

 

8,081

 

333

 

46,419

 

 

 

 

Ideagen plc

 

Group Statement of Changes in Equity for the year ended 30 April 2016

 

 

Share

capital

 

Share

premium

 

Merger

reserve

 

Share-based payments reserve

 

Retained earnings

 

Foreign

currency translation reserve

 

Total

attributable to owners of the parent

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

£'000

 

£'000

 

  £'000

 

£'000

 

£'000

 

  £'000

 

£'000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 1 May 2015

1,773

 

23,443

 

1,167

 

653

 

4,160

 

(7)

 

31,189

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares issued under share option scheme

17

 

155

 

-

 

-

 

-

 

-

 

172

Share-based payments

-

 

-

 

-

 

921

 

-

 

-

 

921

Transfer on exercise of share options

-

 

-

 

-

 

(92)

 

92

 

-

 

-

Taxation on share-based payments in equity

-

 

-

 

-

 

-

 

275

 

-

 

275

Equity dividends paid

-

 

-

 

-

 

-

 

(306)

 

-

 

(306)

Total transactions with owners recognised directly in equity

17

 

155

 

-

 

829

 

61

 

-

 

1,062

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Profit for the year

-

 

-

 

-

 

-

 

1,317

 

-

 

1,317

Other comprehensive income for the year

-

 

-

 

-

 

-

 

27

 

88

 

115

Total comprehensive income for the year

-

 

-

 

-

 

-

 

1,344

 

88

 

1,432

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 30 April 2016

1,790

 

23,598

 

1,167

 

1,482

 

5,565

 

81

 

33,683

 

 

 

Notes

 

1       Basis of information

The financial information included in this preliminary announcement is unaudited. This information does not constitute the annual report and accounts of the Group for the year ended 30 April 2017 within the meaning of section 434 of the Companies Act 2006. This will be available from www.ideagen.com in due course. The audited annual report and accounts of the Group for the year ended 30 April 2016 has been filed with the Registrar of Companies. The auditor's report on those financial statements was unqualified and did not contain any statement under section 498 (2) or (3) of the Companies Act 2006 and did not include references to any matters to which the auditor drew attention by way of emphasis. Consistent accounting policies have been applied in the preparation of this information over the two years ended 30 April 2017.

 

2     Revenue

An analysis of the Group's revenue is given below.

 

2017

 

2016

 

£'000

 

£'000

 

 

 

 

Recurring software revenues

4,785

 

2,055

Recurring support & maintenance

10,685

 

9,885

Total recurring revenues

15,470

 

11,940

Software - new licence revenues

5,493

 

5,255

Professional services

5,723

 

4,439

Other

426

 

302

 

 

 

 

Total revenue

27,112

 

21,936

 

 

3       Earnings per share information

 

Basic earnings per share is calculated by dividing the profit for the year attributable to the owners of the Group ('Earnings') by the weighted average number of ordinary shares outstanding during the year. Diluted earnings per share is calculated by dividing Earnings by the weighted-average number of ordinary shares outstanding during the year as adjusted for the effect of all potentially dilutive shares, including share options.

 

In order to better demonstrate the performance of the Group, adjusted earnings per share calculations have also been presented which take into account items typically adjusted for by users of financial statements. The adjusted earnings and earnings per share information are shown below.

 

2017

 

2016

 

£'000

 

£'000

 

 

 

 

Profit for the year (Earnings)

731

 

1,317

Adjustments:

 

 

 

Costs of acquiring businesses

609

 

-

Restructuring costs

104

 

-

Share-based payment charges

1,203

 

936

Deferred taxation on share based payment charges

78

 

(168)

Amortisation of acquired intangibles

4,318

 

3,715

Deferred taxation on amortisation of acquired intangibles

(977)

 

(851)

Movement in fair value of contingent consideration

-

 

4

Adjusted earnings

6,066

 

4,953

 

 

 

 

Weighted average number of shares

182,719,656

 

178,379,433

Diluted weighted average number of shares

191,847,039

 

186,316,355

Basic earnings per share

0.40 pence

 

0.74 pence

Diluted earnings per share

0.38 pence

 

0.71 pence

Adjusted basic earnings per share

3.32 pence

 

2.78 pence

Adjusted diluted earnings per share

3.16 pence

 

2.66 pence

 

 

4       Taxation

Further information on the taxation credit in the Group Statement of Comprehensive Income is as follows:

 

 

 

 

2017

£'000

 

2016

£'000

 

 

 

 

 

 

UK income tax charge / (credit)

 

 

228

 

(15)

Overseas income tax charge

 

 

53

 

34

 

 

 

281

 

19

 

 

 

 

 

 

Deferred tax credit on amortisation of acquisition intangibles

 

 

(977)

 

(851)

Deferred tax charge / (credit) on share based payment charges

 

 

78

 

(168)

Deferred tax charge on utilisation of tax losses

 

 

222

 

442

Deferred tax charge on development costs

 

 

328

 

243

Total deferred taxation credit

 

 

(349)

 

(334)

 

 

 

 

 

 

Total taxation credit

 

 

(68)

 

(315)

 

5       Adjusted profit before taxation and adjusted taxation charge in the Income Statement

 

 

 

 

2017

£'000

 

2016

£'000

 

 

 

 

 

 

Adjusted earnings (note 3)

 

 

6,066

 

4,953

Adjusted taxation charge (below)

 

 

831

 

704

Adjusted profit before taxation

 

 

6,897

 

5,657

 

 

 

 

 

 

Taxation (credit)/charge in the Statement of Comprehensive Income

 

 

(68)

 

(315)

Add back:

 

 

 

 

 

Deferred tax credit on amortisation of acquisition intangibles (note 3)

 

 

977

 

851

Deferred tax credit on share based payment charges (note 3)

 

 

(78)

 

168

Adjusted taxation charge

 

 

831

 

704

 

 

 

 

 

 

Adjusted taxation charge based on adjusted profit before taxation

 

 

12%

 

12%

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR LLFSRDFIDLID

a d v e r t i s e m e n t